![]() |
Volumn 20, Issue 4, 2010, Pages 1432-1435
|
Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors
|
Author keywords
Atherosclerosis; CETP; CETP inhibitors; Cholesteryl ester transfer protein; HDL C
|
Indexed keywords
2,3 DIHYDRO 3,8 DIPHENYLBENZO[1,4]OXAZINE DERIVATIVE;
CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
UNCLASSIFIED DRUG;
ALKYLATION;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
BROMINATION;
CHIRALITY;
CHOLESTEROL BLOOD LEVEL;
CONTROLLED STUDY;
DISTRIBUTION VOLUME;
DRUG BIOAVAILABILITY;
DRUG HALF LIFE;
DRUG INHIBITION;
DRUG SYNTHESIS;
ENANTIOSELECTIVITY;
FEMALE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
IC 50;
LIVER MICROSOME;
MALE;
METHYLATION;
MOUSE;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
TIME TO MAXIMUM PLASMA CONCENTRATION;
ADMINISTRATION, ORAL;
ANIMALS;
BENZOXAZINES;
CHOLESTEROL ESTER TRANSFER PROTEINS;
CRICETINAE;
DRUG DESIGN;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
INHIBITORY CONCENTRATION 50;
MALE;
MICE;
MICE, TRANSGENIC;
MOLECULAR STRUCTURE;
RATS;
CRICETINAE;
MUS MUSCULUS;
RATTUS;
|
EID: 75749090371
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2009.12.096 Document Type: Article |
Times cited : (38)
|
References (26)
|